• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of clinexpimmunolLink to Publisher's site
Clin Exp Immunol. Jul 1984; 57(1): 123–129.
PMCID: PMC1536082

Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis.


The depressed cell-mediated immunity in rheumatoid arthritis was investigated in vivo by cutaneous hypersensitivity responses to seven antigens including tuberculin PPD, and in vitro by lymphocyte transformation to the latter antigen. In vivo 40% of rheumatoid patients were anergic compared to 2% of controls (P less than 0.001) with an associated reduction in sum score (5.9 +/- 6.5 vs 15.3 +/- 8.7, P less than 0.001). In vitro lymphocyte proliferation to PPD was also significantly depressed (P less than 0.001) and could not be reversed by indomethacin. A significant correlation between the in vivo sum scored (induration in mm) and in vitro thymidine incorporation (d/min) (r = 0.59, P less than 0.001) was found. In an attempt to overcome the depressed in vitro response the addition of a crude supernatant from a mixed lymphocyte reaction was found to return the PPD stimulated lymphocyte proliferation to the normal range. This effect was mimicked by purified IL-2 but not purified IL-1. The implications of this finding are are discussed.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (811K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Alcocer-Varela J, Alarcón-Segovia D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest. 1982 Jun;69(6):1388–1392. [PMC free article] [PubMed]
  • Andersson J, Grönvik KO, Larsson EL, Coutinho A. Studies on T lymphocyte activation. I. Requirements for the mitogen-dependent production of T cell growth factors. Eur J Immunol. 1979 Aug;9(8):581–587. [PubMed]
  • Goodwin JS, Messner RP, Bankhurst AD, Peake GT, Saiki JH, Williams RC., Jr Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med. 1977 Nov 3;297(18):963–968. [PubMed]
  • Goodwin JS, DeHoratius R, Israel H, Peake GT, Messner RP. Suppressor cell function in sarcoidosis. Ann Intern Med. 1979 Feb;90(2):169–173. [PubMed]
  • Haregewoin A, Godal T, Mustafa AS, Belehu A, Yemaneberhan T. T-cell conditioned media reverse T-cell unresponsiveness in lepromatous leprosy. Nature. 1983 May 26;303(5915):342–344. [PubMed]
  • Harel-Bellan A, Joskowicz M, Fradelizi D, Eisen H. Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3466–3469. [PMC free article] [PubMed]
  • Hopper KE, Cahill JM. Immunoregulation by macrophages II. Separation of mouse peritoneal macrophages having tumoricidal and bactericidal activities and those secreting PGE and interleukin I. J Reticuloendothel Soc. 1983 Jun;33(6):443–456. [PubMed]
  • Lockshin MD, Eisenhauer AC, Kohn R, Weksler M, Block S, Mushlin SB. Cell-mediated immunity in rheumatic diseases. II. Mitogen responses in RA, SLE, and other illnesses: correlation with T- and B-lymphocyte populations. Arthritis Rheum. 1975 May-Jun;18(3):245–250. [PubMed]
  • Mason UG, 3rd, Greenberg LE, Yen SS, Kirkpatrick CH. Indomethacin-responsive mononuclear cell dysfunction in "atypical" mycobacteriosis. Cell Immunol. 1982 Jul 15;71(1):54–65. [PubMed]
  • Miller SD, Jones HE. Correlation of lymphocyte transformation with tuberculin skin-test sensitivity. Am Rev Respir Dis. 1973 Apr;107(4):530–538. [PubMed]
  • Paganelli R, Aiuti F, Beverley PC, Levinsky RJ. Impaired production of interleukins in patients with cell-mediated immunodeficiencies. Clin Exp Immunol. 1983 Feb;51(2):338–344. [PMC free article] [PubMed]
  • Palacios R. Mechanism of T cell activation: role and functional relationship of HLA-DR antigens and interleukins. Immunol Rev. 1982;63:73–110. [PubMed]
  • Panayi GS. Does rheumatoid arthritis have a clinicopathological spectrum similar to that of leprosy? Ann Rheum Dis. 1982 Feb;41(1):102–103. [PMC free article] [PubMed]
  • Patel V, Panayi GS, Shepherd P, Richter M, Harkness J, Gibson T. Lymphocyte studies in rheumatoid arthritis. V. Suppressor cell function in peripheral blood. Scand J Rheumatol. 1982;11(3):133–137. [PubMed]
  • Petersen EA, Neva FA, Oster CN, Bogaert Diaz H. Specific inhibition of lymphocyte-proliferation responses by adherent suppressor cells in diffuse cutaneous leishmaniasis. N Engl J Med. 1982 Feb 18;306(7):387–392. [PubMed]
  • Räsänen L. Skin test reactivity and in vitro responses to microbes and microbial antigens. Clin Exp Immunol. 1980 Jun;40(3):566–572. [PMC free article] [PubMed]
  • Rode HN, Christou NV, Bubenik O, Superina R, Gordon J, Meakins JL, MacLean LD. Lymphocyte function in anergic patients. Clin Exp Immunol. 1982 Jan;47(1):155–161. [PMC free article] [PubMed]
  • ROPES MW, BENNETT GA, COBB S, JACOX R, JESSAR RA. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed]
  • Seitz M, Deimann W, Gram N, Hunstein W, Gemsa D. Characterization of blood mononuclear cells of rheumatoid arthritis patients. I. Depressed lymphocyte proliferation and enhanced prostanoid release from monocytes. Clin Immunol Immunopathol. 1982 Dec;25(3):405–416. [PubMed]
  • Silverman HA, Johnson JS, Vaughan JH, McGlamory JC. Altered lymphocyte reactivity in rheumatoid arthritis. Arthritis Rheum. 1976 May-Jun;19(3):509–515. [PubMed]
  • Turk JL, Bryceson AD. Immunological phenomena in leprosy and related diseases. Adv Immunol. 1971;13:209–266. [PubMed]
  • Watson J, Gillis S, Marbrook J, Mochizuki D, Smith KA. Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines. J Exp Med. 1979 Oct 1;150(4):849–861. [PMC free article] [PubMed]
  • Waxman J, Lockshin MD, Schnapp JJ, Doneson IN. Cellular immunity in rheumatic diseases. I. Rheumatoid arthritis. Arthritis Rheum. 1973 Jul-Aug;16(4):499–506. [PubMed]
  • Wolinsky SI, Goodwin JS, Messner RP, Williams RC., Jr Role of prostaglandin in the depressed cell-mediated immune response in rheumatoid arthritis. Clin Immunol Immunopathol. 1980 Sep;17(1):31–37. [PubMed]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology


Related citations in PubMed

Cited by other articles in PMC

See all...


  • Compound
    PubChem Compound links
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...